Host modulators of H1N1 cytopathogenicity.
Influenza A virus infects 5-20% of the population annually, resulting in ~35,000 deaths and significant morbidity. Current treatments include vaccines and drugs that target viral proteins. However, both of these approaches have limitations, as vaccines require yearly development and the rapid evolut...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3410888?pdf=render |
id |
doaj-c5ff6c95095346579020db8ad8961ee7 |
---|---|
record_format |
Article |
spelling |
doaj-c5ff6c95095346579020db8ad8961ee72020-11-24T22:16:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e3928410.1371/journal.pone.0039284Host modulators of H1N1 cytopathogenicity.Samuel E WardHyun Seok KimKakajan KomurovSaurabh MendirattaPei-Ling TsaiMirco SchmolkeNeal SatterlyBalaji ManicassamyChristian V ForstMichael G RothAdolfo García-SastreKatarzyna M BlazewskaCharles E McKennaBeatriz M FontouraMichael A WhiteInfluenza A virus infects 5-20% of the population annually, resulting in ~35,000 deaths and significant morbidity. Current treatments include vaccines and drugs that target viral proteins. However, both of these approaches have limitations, as vaccines require yearly development and the rapid evolution of viral proteins gives rise to drug resistance. In consequence additional intervention strategies, that target host factors required for the viral life cycle, are under investigation. Here we employed arrayed whole-genome siRNA screening strategies to identify cell-autonomous molecular components that are subverted to support H1N1 influenza A virus infection of human bronchial epithelial cells. Integration across relevant public data sets exposed druggable gene products required for epithelial cell infection or required for viral proteins to deflect host cell suicide checkpoint activation. Pharmacological inhibition of representative targets, RGGT and CHEK1, resulted in significant protection against infection of human epithelial cells by the A/WS/33 virus. In addition, chemical inhibition of RGGT partially protected against H5N1 and the 2009 H1N1 pandemic strain. The observations reported here thus contribute to an expanding body of studies directed at decoding vulnerabilities in the command and control networks specified by influenza virulence factors.http://europepmc.org/articles/PMC3410888?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Samuel E Ward Hyun Seok Kim Kakajan Komurov Saurabh Mendiratta Pei-Ling Tsai Mirco Schmolke Neal Satterly Balaji Manicassamy Christian V Forst Michael G Roth Adolfo García-Sastre Katarzyna M Blazewska Charles E McKenna Beatriz M Fontoura Michael A White |
spellingShingle |
Samuel E Ward Hyun Seok Kim Kakajan Komurov Saurabh Mendiratta Pei-Ling Tsai Mirco Schmolke Neal Satterly Balaji Manicassamy Christian V Forst Michael G Roth Adolfo García-Sastre Katarzyna M Blazewska Charles E McKenna Beatriz M Fontoura Michael A White Host modulators of H1N1 cytopathogenicity. PLoS ONE |
author_facet |
Samuel E Ward Hyun Seok Kim Kakajan Komurov Saurabh Mendiratta Pei-Ling Tsai Mirco Schmolke Neal Satterly Balaji Manicassamy Christian V Forst Michael G Roth Adolfo García-Sastre Katarzyna M Blazewska Charles E McKenna Beatriz M Fontoura Michael A White |
author_sort |
Samuel E Ward |
title |
Host modulators of H1N1 cytopathogenicity. |
title_short |
Host modulators of H1N1 cytopathogenicity. |
title_full |
Host modulators of H1N1 cytopathogenicity. |
title_fullStr |
Host modulators of H1N1 cytopathogenicity. |
title_full_unstemmed |
Host modulators of H1N1 cytopathogenicity. |
title_sort |
host modulators of h1n1 cytopathogenicity. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
Influenza A virus infects 5-20% of the population annually, resulting in ~35,000 deaths and significant morbidity. Current treatments include vaccines and drugs that target viral proteins. However, both of these approaches have limitations, as vaccines require yearly development and the rapid evolution of viral proteins gives rise to drug resistance. In consequence additional intervention strategies, that target host factors required for the viral life cycle, are under investigation. Here we employed arrayed whole-genome siRNA screening strategies to identify cell-autonomous molecular components that are subverted to support H1N1 influenza A virus infection of human bronchial epithelial cells. Integration across relevant public data sets exposed druggable gene products required for epithelial cell infection or required for viral proteins to deflect host cell suicide checkpoint activation. Pharmacological inhibition of representative targets, RGGT and CHEK1, resulted in significant protection against infection of human epithelial cells by the A/WS/33 virus. In addition, chemical inhibition of RGGT partially protected against H5N1 and the 2009 H1N1 pandemic strain. The observations reported here thus contribute to an expanding body of studies directed at decoding vulnerabilities in the command and control networks specified by influenza virulence factors. |
url |
http://europepmc.org/articles/PMC3410888?pdf=render |
work_keys_str_mv |
AT samueleward hostmodulatorsofh1n1cytopathogenicity AT hyunseokkim hostmodulatorsofh1n1cytopathogenicity AT kakajankomurov hostmodulatorsofh1n1cytopathogenicity AT saurabhmendiratta hostmodulatorsofh1n1cytopathogenicity AT peilingtsai hostmodulatorsofh1n1cytopathogenicity AT mircoschmolke hostmodulatorsofh1n1cytopathogenicity AT nealsatterly hostmodulatorsofh1n1cytopathogenicity AT balajimanicassamy hostmodulatorsofh1n1cytopathogenicity AT christianvforst hostmodulatorsofh1n1cytopathogenicity AT michaelgroth hostmodulatorsofh1n1cytopathogenicity AT adolfogarciasastre hostmodulatorsofh1n1cytopathogenicity AT katarzynamblazewska hostmodulatorsofh1n1cytopathogenicity AT charlesemckenna hostmodulatorsofh1n1cytopathogenicity AT beatrizmfontoura hostmodulatorsofh1n1cytopathogenicity AT michaelawhite hostmodulatorsofh1n1cytopathogenicity |
_version_ |
1725790898076254208 |